The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Mutant NPM1 Maintains the Leukemic State through HOX Expression
Open accessAbstract
Summary NPM1 is the most frequently mutated gene in cytogenetically normal acute myeloid leukemia (AML). In AML cells, NPM1 mutations result in abnormal cytoplasmic localization of the mutant protein (NPM1c), however it is unknown whether NPM1c is required to maintain the leukemic state. Here, we show that loss of NPM1c from the cytoplasm, either through nuclear relocalization or targeted degradation, results in immediate downregulation of homeobox (HOX) genes followed by differentiation. Finally, we show that XPO1 inhibition relocalizes NPM1c to the nucleus, promotes differentiation of AML cells, and prolongs survival of Npm1mutated leukemic mice. We describe an exquisite dependency of NPM1-mutant AML cells on NPM1c, providing the rationale for the use of nuclear export inhibitors in AML with mutated NPM1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
FIMO: scanning for occurrences of a given motif
Grant, C. E., Bailey, T. L., & Noble, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr064 · Cited by 4,247
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Self-citationdeepTools: a flexible platform for exploring deep-sequencing data
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A., & Manke, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku365 · Cited by 3,738
CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals
Fornerod, M., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,081
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Self-citationIdentifying ChIP-seq enrichment using MACS
Feng, J., Liu, T., Qin, B., Zhang, Y., & Liu, X. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.101 · Cited by 1,870
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo
Moreno-Mateos, M. A., Vejnar, C. E., Beaudoin, J.-D., Fernandez, J. P., Mis, E. K., Khokha, M. K., & Giraldez, A. J. (2015) · Nature Methods · doi:10.1038/nmeth.3543 · Cited by 1,290
The dTAG system for immediate and target-specific protein degradation
Nabet, B., Roberts, J. M., Buckley, D. L., Paulk, J., Dastjerdi, S., Yang, A., Leggett, A. L., Erb, M. A., Lawlor, M. A., Souza, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0021-8 · Cited by 1,118
Self-citationGrisendi, S., Mecucci, C., Falini, B., & Pandolfi, P. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1885 · Cited by 850
Self-citationAssessment of Minimal Residual Disease in Standard-Risk AML
Ivey, A., Hills, R. K., Simpson, M. A., Jovanovic, J. V., Gilkes, A., Grech, A., Patel, Y., Bhudia, N., Farah, H., Mason, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507471 · Cited by 845
Tzelepis, K., Koike-Yusa, H., De Braekeleer, E., Li, Y., Metzakopian, E., Dovey, O. M., Mupo, A., Grinkevich, V., Li, M., Mazan, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.079 · Cited by 761
Analysis and prediction of leucine-rich nuclear export signals
la Cour, T., Kiemer, L., Mølgaard, A., Gupta, R., Skriver, K., & Brunak, S. (2004) · Protein Engineering, Design and Selection · doi:10.1093/protein/gzh062 · Cited by 759
Kyba, M., Perlingeiro, R. C. R., & Daley, G. Q. (2002) · Cell · doi:10.1016/s0092-8674(02)00680-3 · Cited by 655
Wang, T., Yu, H., Hughes, N. W., Liu, B., Kendirli, A., Klein, K., Chen, W. W., Lander, E. S., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.01.013 · Cited by 632
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
Brown, J. D., Lin, C. Y., Duan, Q., Griffin, G., Federation, A. J., Paranal, R. M., Bair, S., Newton, G., Lichtman, A. H., Kung, A. L., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.024 · Cited by 614
Self-citationFalini, B., Nicoletti, I., Martelli, M. F., & Mecucci, C. (2007) · Blood · doi:10.1182/blood-2006-07-012252 · Cited by 565
Self-citationRole of nucleophosmin in embryonic development and tumorigenesis
Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L., Manova, K., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03915 · Cited by 561
ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors
Schmidl, C., Rendeiro, A. F., Sheffield, N. C., & Bock, C. (2015) · Nature Methods · doi:10.1038/nmeth.3542 · Cited by 509
Sauvageau, G., Lansdorp, P. M., Eaves, C. J., Hogge, D. E., Dragowska, W. H., Reid, D. S., Largman, C., Lawrence, H. J., & Humphries, R. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12223 · Cited by 497
Hox genes in hematopoiesis and leukemogenesis
Argiropoulos, B., & Humphries, R. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210760 · Cited by 492 · cited 2×
“Overexpression of Hox genes in murine hematopoietic progenitors causes increased cell growth and leukemia development, which is accelerated by co-overexpression with Meis1 (Argiropoulos and Humphries, 2007; Sauvageau et al., 1997).”
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
Grimwade, D., Ivey, A., & Huntly, B. J. P. (2016) · Blood · doi:10.1182/blood-2015-07-604496 · Cited by 445
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
Kogan, S. C., Ward, J. M., Anver, M. R., Berman, J. J., Brayton, C., Cardiff, R. D., Carter, J. S., de Coronado, S., Downing, J. R., Fredrickson, T. N., et al. (2002) · Blood · doi:10.1182/blood.v100.1.238 · Cited by 418
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Lin, C. Y., Erkek, S., Tong, Y., Yin, L., Federation, A. J., Zapatka, M., Haldipur, P., Kawauchi, D., Risch, T., Warnatz, H.-J., et al. (2016) · Nature · doi:10.1038/nature16546 · Cited by 380
Self-citationAlcalay, M., Tiacci, E., Bergomas, R., Bigerna, B., Venturini, E., Minardi, S. P., Meani, N., Diverio, D., Bernard, L., Tizzoni, L., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0560 · Cited by 357
Self-citationNUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights
Gough, S. M., Slape, C. I., & Aplan, P. D. (2011) · Blood · doi:10.1182/blood-2011-07-328880 · Cited by 342
Falini, B. (2006) · Blood · doi:10.1182/blood-2005-11-4745 · Cited by 281
Self-citationDoulatov, S., Vo, L. T., Chou, S. S., Kim, P. G., Arora, N., Li, H., Hadland, B. K., Bernstein, I. D., Collins, J. J., Zon, L. I., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.002 · Cited by 277
Nucleo-cytoplasmic transport as a therapeutic target of cancer
Gravina, G. L., Senapedis, W., McCauley, D., Baloglu, E., Shacham, S., & Festuccia, C. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0085-1 · Cited by 275
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Gundry, M. C., Brunetti, L., Lin, A., Mayle, A. E., Kitano, A., Wagner, D., Hsu, J. I., Hoegenauer, K. A., Rooney, C. M., Goodell, M. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.092 · Cited by 265 · cited 2×
“For gene disruption experiments in cell lines, sgRNAs were synthetized as previously described (Brunetti et al., 2018; Gundry et al., 2016).”
Self-citationTargeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
Kühn, M. W. M., Song, E., Feng, Z., Sinha, A., Chen, C.-W., Deshpande, A. J., Cusan, M., Farnoud, N., Mupo, A., Grove, C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0237 · Cited by 264
Abdul Razak, A. R., Mau-Soerensen, M., Gabrail, N. Y., Gerecitano, J. F., Shields, A. F., Unger, T. J., Saint-Martin, J. R., Carlson, R., Landesman, Y., McCauley, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3949 · Cited by 245
Falini, B., Bolli, N., Liso, A., Martelli, M. P., Mannucci, R., Pileri, S., & Nicoletti, I. (2009) · Leukemia · doi:10.1038/leu.2009.124 · Cited by 239
Self-citationLee, B. H., Tothova, Z., Levine, R. L., Anderson, K., Buza-Vidas, N., Cullen, D. E., McDowell, E. P., Adelsperger, J., Fröhling, S., Huntly, B. J. P., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.031 · Cited by 230
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
Ranganathan, P., Yu, X., Na, C., Santhanam, R., Shacham, S., Kauffman, M., Walker, A., Klisovic, R., Blum, W., Caligiuri, M., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423160 · Cited by 220
Biological and clinical consequences of NPM1 mutations in AML
Heath, E. M., Chan, S. M., Minden, M. D., Murphy, T., Shlush, L. I., & Schimmer, A. D. (2017) · Leukemia · doi:10.1038/leu.2017.30 · Cited by 209
Embryonic stem cell-derived hematopoietic stem cells
Wang, Y., Yates, F., Naveiras, O., Ernst, P., & Daley, G. Q. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506127102 · Cited by 205
Claes, B., Delmar, P., Yesilyurt, B. T., Reumers, J., Mazzone, M., Devlieger, R., Wildiers, H., de Haas, S., Carmeliet, P., Cutsem, E. V., et al. (2012) · Research Portal (Queen's University Belfast) · doi:10.1158/1538-7445 · Cited by 194
Etchin, J., Sanda, T., Mansour, M. R., Kentsis, A., Montero, J., Le, B. T., Christie, A. L., McCauley, D., Rodig, S. J., Kauffman, M., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12231 · Cited by 182
Sauvageau, G., Thorsteinsdottir, U., Hough, M. R., Hugo, P., Lawrence, H. J., Largman, C., & Humphries, R. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80238-1 · Cited by 181
MELK is not necessary for the proliferation of basal-like breast cancer cells
Huang, H.-T., Seo, H.-S., Zhang, T., Wang, Y., Jiang, B., Li, Q., Buckley, D. L., Nabet, B., Roberts, J. M., Paulk, J., et al. (2017) · eLife · doi:10.7554/elife.26693 · Cited by 177
Self-citationGounder, M. M., Zer, A., Tap, W. D., Salah, S., Dickson, M. A., Gupta, A. A., Keohan, M. L., Loong, H. H., D’Angelo, S. P., Baker, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.6346 · Cited by 164
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
Quentmeier, H., Martelli, M. P., Dirks, W. G., Bolli, N., Liso, A., MacLeod, R. A. F., Nicoletti, I., Mannucci, R., Pucciarini, A., Bigerna, B., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403899 · Cited by 160
Self-citationA phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
Garzon, R., Savona, M. R., Baz, R., Andreeff, M., Gabrail, N. Y., Gutierrez, M. E., Savoie, L., Mau‐Sørensen, M., Wagner‐Johnston, N., Yee, K. W. L., et al. (2017) · Blood · doi:10.1182/blood-2016-11-750158 · Cited by 149
Martelli, M. P., Gionfriddo, I., Mezzasoma, F., Milano, F., Pierangeli, S., Mulas, F., Pacini, R., Tabarrini, A., Pettirossi, V., Rossi, R., et al. (2015) · Blood · doi:10.1182/blood-2014-11-611459 · Cited by 139
Self-citationBalusu, R., Fiskus, W. C., Rao, R., Chong, D. G., Nalluri, S., Mudunuru, U., Ma, H., Chen, L., Venkannagari, S., Ha, K., et al. (2011) · Blood · doi:10.1182/blood-2010-09-309674 · Cited by 139
Spencer, D. H., Young, M. A., Lamprecht, T. L., Helton, N., Fulton, R. S., O’Laughlin, M. D., Fronick, C. C., Magrini, V. J., Demeter, R., Miller, C. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.6 · Cited by 134
Chen, C. I., Siegel, D. S. D., Gutierrez, M. E., Jacoby, M. A., Hofmeister, C. C., Gabrail, N. Y., Baz, R., Mau‐Sørensen, M., Berdeja, J. G., Savona, M. R., et al. (2017) · Blood · doi:10.1182/blood-2017-08-797886 · Cited by 132
Bolli, N., Nicoletti, I., Marco, M., Bigerna, B., Pucciarini, A., Mannucci, R., Martelli, M. P., Liso, A., Mecucci, C., Fabbiano, F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0273 · Cited by 119
Self-citationDovey, O. M., Cooper, J. L., Mupo, A., Grove, C. S., Lynn, C., Conte, N., Andrews, R., Pacharne, S., Tzelepis, K., Vijayabaskar, M. S., et al. (2017) · Blood · doi:10.1182/blood-2017-01-760595 · Cited by 97
Chen, Y., Camacho, S. C., Silvers, T. R., Razak, A. R. A., Gabrail, N. Y., Gerecitano, J. F., Kalir, E., Pereira, E. B., Evans, B. R., Ramus, S. J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1333 · Cited by 91
Mupo, A., Celani, L., Dovey, O. M., Cooper, J. L., Grove, C. S., Rad, R., Sportoletti, P., Falini, B., Bradley, A., & Vassiliou, G. S. (2013) · Leukemia · doi:10.1038/leu.2013.77 · Cited by 90
Self-citationOka, M., Mura, S., Yamada, K., Sangel, P., Hirata, S., Maehara, K., Kawakami, K., Tachibana, T., Ohkawa, Y., Kimurâ, H., et al. (2016) · eLife · doi:10.7554/elife.09540 · Cited by 83
Ramsey, S. A., Knijnenburg, T., Kennedy, K. A., Zak, D. E., Gilchrist, M., Gold, E. S., Johnson, C. D., Lampano, A., Litvak, V., Navarro, G., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq405 · Cited by 74
Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
Nakayama, R. T., Zhang, Y., Czaplinski, J. T., Anatone, A. J., Sicińska, E., Fletcher, J. A., Demetri, G. D., & Wagner, A. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7667 · Cited by 74
NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model
Mallardo, M., Caronno, A., Pruneri, G., Raviele, P. R., Viale, A., Pelicci, P. G., & Colombo, E. (2013) · Leukemia · doi:10.1038/leu.2013.114 · Cited by 48
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model
Sportoletti, P., Varasano, E., Rossi, R., Bereshchenko, O., Cecchini, D., Gionfriddo, I., Bolli, N., Tiacci, E., Intermesoli, T., Zanghì, P., et al. (2013) · Blood · doi:10.1182/blood-2012-08-449553 · Cited by 38
Self-citationFalini, B., Sportoletti, P., Brunetti, L., & Martelli, M. P. (2015) · British Journal of Haematology · doi:10.1111/bjh.13409 · Cited by 38
Self-citationA western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
Martelli, M. P., Manes, N., Liso, A., Pettirossi, V., Galletti, B., Bigerna, B., Pucciarini, A., Marco, M., Pallotta, M. T., Bolli, N., et al. (2008) · Leukemia · doi:10.1038/leu.2008.149 · Cited by 28
Self-citationHighly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Brunetti, L., Gundry, M. C., Kitano, A., Nakada, D., & Goodell, M. A. (2018) · Journal of Visualized Experiments · doi:10.3791/57278 · Cited by 24
Self-citationDetection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell line
Thanh, H., Vũ, H. A., Iwasaki, R., Nagamura, F., Tojo, A., Watanabe, T., & Sato, Y. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.09.019 · Cited by 16
Cited by
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
van Galen, P., Hovestadt, V., Wadsworth II, M. H., Hughes, T. K., Griffin, G. K., Battaglia, S., Verga, J. A., Stephansky, J., Pastika, T. J., Lombardi Story, J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.031 · Cited by 1,164
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
Burslem, G. M., & Crews, C. M. (2020) · Cell · doi:10.1016/j.cell.2019.11.031 · Cited by 1,079
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Nabet, B., Ferguson, F. M., Seong, B. K. A., Kuljanin, M., Leggett, A. L., Mohardt, M. L., Robichaud, A., Conway, A. S., Buckley, D. L., Mancias, J. D., et al. (2020) · doi:10.1101/2020.03.13.980946 · Cited by 312
Self-citationTherapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
Uckelmann, H. J., Kim, S. M., Wong, E. M., Hatton, C., Giovinazzo, H., Gadrey, J. Y., Krivtsov, A. V., Rücker, F. G., Döhner, K., McGeehan, G. M., et al. (2020) · Science · doi:10.1126/science.aax5863 · Cited by 257
Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery
Pei, J., Wang, G., Feng, L., Zhang, J., Jiang, T., Sun, Q., & Ouyang, L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01689 · Cited by 124
Metadata
- Authors
- Brunetti, L., Gundry, M. C., Sorcini, D., Guzman, A. G., Huang, Y.-H., Ramabadran, R., Gionfriddo, I., Mezzasoma, F., Milano, F., Nabet, B., Buckley, D. L., Kornblau, S. M., Lin, C. Y., Sportoletti, P., Martelli, M. P., Falini, B., & Goodell, M. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 34
- Issue
- 3
- Pages
- 499-512.e9
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2890477656
- Cited by
- 313
- References
- 69
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.